Association between Endotoxin Activity and Acute Kidney Injury in Cardiac Patients Undergoing Cardiopulmonary Bypass (original) (raw)
Circulating Endotoxin and Cytokines after Cardiopulmonary Bypass: Differential Correlation with Duration of Bypass and Systemic Inflammatory Response/Multiple Organ Dysfunction Syndromes
FAREED KHOUQEER
Clinical Immunology and Immunopathology, 1997
View PDFchevron_right
Bypass Surgery The Impact of Anti-Endotoxin Core Antibodies on Endotoxin and Cytokine Release and Ventilation Time After Cardiac Surgery
Rasjid Soeparwata
2016
View PDFchevron_right
Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational study
Francoise Briet
Critical Care, 2011
View PDFchevron_right
Endotoxin release in cardiac surgery with cardiopulmonary bypass: pathophysiology and possible therapeutic strategies. An update
JPAM Schonberger
European Journal of Cardio-Thoracic Surgery, 2011
View PDFchevron_right
The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery
Rasjid Soeparwata
Acc Current Journal Review, 2001
View PDFchevron_right
Relationship Between Preoperative Endotoxin Immune Status, Gut Perfusion, and Outcome From Cardiac Valve Replacement Surgery
George R Barclay
CHEST Journal, 1997
View PDFchevron_right
Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation
gin c
Annals of Thoracic Surgery, 1992
View PDFchevron_right
Serum Interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study
Christopher Altmann
Critical Care, 2009
View PDFchevron_right
Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes
Alessandra Brocca
Blood Purification
View PDFchevron_right
Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia
Piet Jansen, Heleen Straaten
Intensive Care Medicine, 1996
View PDFchevron_right
Methylprednisolone does not influence endotoxin translocation during cardiopulmonary bypass
Michael Karlstad
Journal of Cardiothoracic and Vascular Anesthesia, 1993
View PDFchevron_right
Higher cytotoxic activity and increased levels of IL-1β, IL-6, and TNF-α in patients undergoing cardiopulmonary bypass
Francesc Marti
American Journal of Hematology, 1995
View PDFchevron_right
Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children
Peter Rimensberger
Cardiology in The Young, 2003
View PDFchevron_right
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update
Domenico Paparella
European Journal of Cardio-Thoracic Surgery, 2002
View PDFchevron_right
Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment
G. Nieman
The journal of extra-corporeal technology, 1999
View PDFchevron_right
Endotoxin-neutralizing capacity of serum from cardiac surgical patients
George R Barclay
Journal of Cardiothoracic and Vascular Anesthesia, 2001
View PDFchevron_right
Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass
chi huynh
Journal of Thoracic and Cardiovascular Surgery, 1999
View PDFchevron_right
Perioperative and postoperative course of cytokines and the metabolic activity of neutrophils in human cardiac operations and heart transplantation
Lukas Kubala
The Journal of Thoracic and Cardiovascular Surgery, 2002
View PDFchevron_right
Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury
Manuel Fontes
The Annals of Thoracic Surgery, 2003
View PDFchevron_right
Endotoxin and renal function: perspectives to the understanding of septic acute renal failure and toxic shock
riaz khan
Nephrology Dialysis Transplantation, 1999
View PDFchevron_right
Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass
Jean-Marie Desmet
The Journal of Thoracic and Cardiovascular Surgery, 1996
View PDFchevron_right
Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation
Alessandra Brocca
Kidney & blood pressure research, 2016
View PDFchevron_right
Prophylactic Use of Immunoglobulins in Cardiac Surgery
Hans Kress
Sepsis, 1999
View PDFchevron_right
Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass
G. Nieman
The Journal of Extra Corporeal Technology, 2005
View PDFchevron_right
The inflammatory response to cardiopulmonary bypass: part 2--anti-inflammatory therapeutic strategies
Charles Vincent
Journal of Cardiothoracic and Vascular Anesthesia, 2009
View PDFchevron_right
Association of IL6 and IL10 with renal dysfunction and the use of haemofiltration during cardiopulmonary bypass☆
Ragheb HASAN
European Journal of Cardio-Thoracic Surgery, 2009
View PDFchevron_right
Managing the inflammatory response after cardiopulmonary bypass: review of the studies in animal models
Gabriel Liguori, Alexandre Kanas, Luiz Felipe Pinho Moreira
Revista Brasileira de Cirurgia Cardiovascular, 2014
View PDFchevron_right